ArticleCancers2024

The Significance of Longitudinal Psoas Muscle Loss in Predicting the Maintenance Efficacy of Durvalumab Treatment Following Concurrent Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer: A Retrospective Study.

Haruka Kuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.